financetom
Business
financetom
/
Business
/
National Bank Lodges Improved Q3 Earnings Driven By "Good Performance" Across Units, Moves to Complete CWB Acquisition
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
National Bank Lodges Improved Q3 Earnings Driven By "Good Performance" Across Units, Moves to Complete CWB Acquisition
Aug 28, 2024 4:23 AM

06:58 AM EDT, 08/28/2024 (MT Newswires) -- National Bank (NA.TO) on Wednesday lodged improved earnings for the third quarter driven by "good performance" across its units as it moves to complete the acquisition of rival Canadian Western Bank ( CWESF ) .

National Bank reported adjusted net income, which excludes specified items -- notably the items related to the agreement to acquire CWB recorded during the third quarter of 2024 -- totalled $960 million compared to $781 million in the same quarter of 2023. Adjusted diluted earnings per share stood at $2.68 compared to $2.18 in the third quarter of 2023.

Net income came in at $1,033 million, up 24% from $830 million in the third quarter of 2023. Third-quarter diluted earnings per share stood at $2.89 compared to $2.33 in the third quarter of 2023. National Bank said these increases were driven by good performance in all of the business segments.

Capital IQ had different comparable estimates on earnings, and this likely reflects adjustments in the bank's results.

On the business segments, within Personal and Commercial, provisions for credit losses rose $4 million.

The bank will pay a dividend of $1.10 per common share for the quarter ending October 31, payable on November 1.

On Capital Management, as at July 31, the Common Equity Tier 1 capital ratio under Basel III stood at 13.5%, unchanged from October 31, 2023. As at July 31, 2024, the Basel III leverage ratio was 4.4%, unchanged from October 31, 2023.

On June 11, National Bank agreed to buy all of CWB's outstanding common shares by way of a share exchange valuing CWB at near $5 billion. National Bank said the transaction will enable it to "accelerate its growth" across Canada. The transaction is subject to the satisfaction of customary closing conditions, including regulatory approvals, and is expected to close in 2025.

"Our strong financial results for the third quarter reflect our diversified earnings mix and solid credit profile as well as disciplined execution across the Bank," said National Bank President and Chief Executive Laurent Ferreira. "With our prudent approach to capital, credit, and costs, we remain well-positioned in a complex macro environment and we look forward to the growth opportunities ahead."

National Bank saw its shares ease $0.74 to $119.89 on the TSX yesterday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Rapport Therapeutics Reports Correlation Between Seizure Biomarker, Clinical Seizures
Rapport Therapeutics Reports Correlation Between Seizure Biomarker, Clinical Seizures
Dec 6, 2024
12:36 PM EST, 12/06/2024 (MT Newswires) -- Rapport Therapeutics ( RAPP ) said Friday that data from a proof-of-concept study of RAP-219 showed a link between a seizure biomarker and clinical seizures. The data showed that a 30% reduction in long episode frequency was associated with a decrease of at least 50% in clinical seizures, regardless of the antiseizure medication...
Bank of Marin Bancorp Names Dave Bonaccorso as Next CFO
Bank of Marin Bancorp Names Dave Bonaccorso as Next CFO
Dec 6, 2024
12:30 PM EST, 12/06/2024 (MT Newswires) -- Bank of Marin Bancorp ( BMRC ) said Friday that Dave Bonaccorso has been named chief financial officer and principal accounting officer, effective Jan 2. Bonaccorso is currently the bank's treasurer. He succeeds Tani Girton, who is retiring next year. Price: 24.80, Change: -0.26, Percent Change: -1.04 ...
Elevance Health Stock Falls As Anthem Faces Backlash Over Anesthesia Policy, Announces Reversal
Elevance Health Stock Falls As Anthem Faces Backlash Over Anesthesia Policy, Announces Reversal
Dec 6, 2024
When Anthem Blue Cross Blue Shield said it will no longer pay for anesthesia care if the surgery or procedure exceeds an arbitrary time limit, parent company Elevance Health Inc ( ELV ) faced backlash and reneged on the policy change. What Happened: In an update on Thursday, Elevance stated: “Based on feedback received and misinterpretation of our policy change,...
Mike Tyson sued in UK for ditching promotion deal to fight Jake Paul
Mike Tyson sued in UK for ditching promotion deal to fight Jake Paul
Dec 6, 2024
LONDON, Dec 6 (Reuters) - Mike Tyson is being sued in a London court for nearly 1.5 million euros ($1.59 million) for allegedly breaking a deal to promote a gambling company in order to fight social media influencer-turned-prizefighter Jake Paul. Medier, a Cyprus-registered company that promotes online casino and betting company Rabona, is suing the former heavyweight champion and his...
Copyright 2023-2026 - www.financetom.com All Rights Reserved